Provider
Instacart confidentially filed for an initial public offering with the Securities and Exchange Commission earlier this year.
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
The JMIR study found themes like cost, functionality, progress tracking and educational content were important to consumers.
The technology uses heart rate variability measurements to assess the severity of sepsis in ED patients.
It will be used to test implants for hip and knee replacements.
A recent study found patients using virtual reality while undergoing hand surgery required less anesthesia during surgery.
Also, digital health company RaphaCure has launched its mobile corporate wellness app.
Curative is shifting from COVID-19 testing to launching a new health plan as testing needs decrease.